Drugs / EX1000
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00698802 | Jun 2008 → Mar 2009 | type 2 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
| Phase 2 | NCT00660374 | Feb 2008 → Mar 2009 | type 2 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EX1000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00698802 ↗ |
| Route | Subcutaneous | “injection s.c.” NCT00660374 ↗ |